Policy | July 23, 2024
Industry hails Union Budget 2024-25
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
The built-in AI-trained algorithms will empower users to proactively intervene when their glucose levels require attention and before a complication can even occur
The academy has secured partnerships with 15 esteemed hospitals
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
_256_384.jpg)
Cipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline Depot (Lanreotide) Injection
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Subscribe To Our Newsletter & Stay Updated
